# ROSUVASTATIN CALCIUM
> **ANDA206513** · Abbreviated New Drug Application (Generic) · Sponsor: ZHEJIANG JINGXIN · Approved 2019-03-01
## Drug
- **FDA Application Number:** ANDA206513
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ROSUVASTATIN CALCIUM
- **Generic name:** ROSUVASTATIN
- **Active ingredients:** ROSUVASTATIN CALCIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ZHEJIANG JINGXIN
- **Manufacturer:** AiPing Pharmaceutical, Inc.
- **First approval:** 2019-03-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206513)
---
*AI Analytics · CC0 1.0*